by Clinical Neuropsychologist Online | Monday, August 5, 2024 | Dementia
Abstract INTRODUCTION The Health and Retirement Study International Partner Surveys (HRS IPS) have rich longitudinal data, but the brevity of cognitive batteries is a limitation. METHODS We used data from a substudy of the English Longitudinal Study of Ageing (ELSA)...
by Clinical Neuropsychologist Online | Saturday, August 3, 2024 | Dementia
Abstract INTRODUCTION We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS We...
by Clinical Neuropsychologist Online | Saturday, August 3, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Timothy Daly, Kasper P. Kepp, Bruno P. Imbimbo | August 3, 2024...
by Clinical Neuropsychologist Online | Friday, August 2, 2024 | Dementia
Abstract INTRODUCTION Triggering receptor expressed on myeloid cells 2 (TREM2) agonists are being clinically evaluated as disease-modifying therapeutics for Alzheimer’s disease. Clinically translatable pharmacodynamic (PD) biomarkers are needed to confirm drug...
by Clinical Neuropsychologist Online | Thursday, August 1, 2024 | Dementia
Abstract INTRODUCTION We disclosed amyloid positron emission tomography (PET) results in individuals with subjective cognitive decline (SCD) and studied patient experiences and outcomes over a 6-month period. METHODS Fifty-seven participants from the Subjective...
